Serum Institute rejects charges levelled by vaccine trial participant, will seek Rs 100 crore in damages

A 40-year-old man who took part in the 'Covidshield' vaccine trial in Chennai has alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions and has sought Rs 5 crore compensation in a legal notice to Serum Institute and others, besides seeking a halt to the trial.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news